$Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.$

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.

OBJECTIVES: Conventional therapy of Wegener's granulomatosis with cyclophosphamide and corticosteroids is limited by incomplete remissions and a high relapse rate. The efficacy and safety of an alternative immunosuppressive drug, deoxyspergualin, was evaluated in patients with relapsing or ref...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Flossmann, O, Baslund, B, Bruchfeld, A, Tervaert, J, Hall, C, Heinzel, P, Hellmich, B, Luqmani, R, Nemoto, K, Tesar, V, Jayne, DR
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2009

Παρόμοια τεκμήρια

Prospective clinical trial of Gusperimus (deoxyspergualin) in refractory Wegener's granulomatosis
ανά: Flossmann, O, κ.ά.
Έκδοση: (2007)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
ανά: Falk, R, κ.ά.
Έκδοση: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
ανά: Falk, R, κ.ά.
Έκδοση: (2011)

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
ανά: Falk, R, κ.ά.
Έκδοση: (2011)

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
ανά: Falk, R, κ.ά.
Έκδοση: (2011)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
ανά: Lockwood, C, κ.ά.
Έκδοση: (1996)

Long-term damage to the ENT system in Wegener's granulomatosis.
ανά: Martinez Del Pero, M, κ.ά.
Έκδοση: (2011)

BIMODAL MORTALITY RISK IN WEGENER'S GRANULOMATOSIS
ανά: Luqmani, R, κ.ά.
Έκδοση: (2009)

An unusual cause of death in Wegener's granulomatosis.
ανά: Suresh, E, κ.ά.
Έκδοση: (2006)

THE USE OF THE INTERNET IN WEGENER'S GRANULOMATOSIS PATIENTS
ανά: Kong, CSM, κ.ά.
Έκδοση: (2003)

Mortality in Wegener's granulomatosis: a bimodal pattern.
ανά: Luqmani, R, κ.ά.
Έκδοση: (2011)

Bimodal mortality risk in Wegener's granulomatosis
ανά: Luqmani, R, κ.ά.
Έκδοση: (2009)

Inner ear deafness in Wegener's granulomatosis.
ανά: Luqmani, R, κ.ά.
Έκδοση: (1991)

Pleural Wegener's granulomatosis: a rare presentation.
ανά: Faratian, D, κ.ά.
Έκδοση: (2009)

Regional anesthesia in Wegener's granulomatosis.
ανά: Pandit, J, κ.ά.
Έκδοση: (1998)

Ocular manifestations of classical and limited Wegener's granulomatosis.
ανά: Stavrou, P, κ.ά.
Έκδοση: (1993)

Damage from Wegener's granulomatosis and its treatment: Prospective data from the Wegener's granulomatosis Etanercept Trial (WGET).
ανά: Seo, P, κ.ά.
Έκδοση: (2004)

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
ανά: Seo, P, κ.ά.
Έκδοση: (2005)

Classical versus non-renal Wegener's granulomatosis.
ανά: Luqmani, R, κ.ά.
Έκδοση: (1994)

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2005)

Design of the Wegener's Granulomatosis Etanercept Trial (WGET)
ανά: Stone, J, κ.ά.
Έκδοση: (2002)

A model to predict cardiovascular events in patients with newly diagnosed wegener's granulomatosis and microscopic polyangiitis.
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis.
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

A MODEL TO PREDICT CARDIOVASCULAR EVENTS IN PATIENTS WITH NEWLY DIAGNOSED WEGENER'S GRANULOMATOSIS AND MICROSCOPIC POLYANGIITIS
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

Wegener's granulomatosis: a case report and literature review
ανά: Tang, Jyh Jong, κ.ά.
Έκδοση: (2010)

Intestinal perforation and jejunal haemorrhage due to Wegener's granulomatosis.
ανά: Strivens, R, κ.ά.
Έκδοση: (2005)

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.
ανά: Merkel, P, κ.ά.
Έκδοση: (2005)

Factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis
ανά: Luqmani, R, κ.ά.
Έκδοση: (2007)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
ανά: Lockwood, C, κ.ά.
Έκδοση: (1995)

Modified Birmingham vasculitis activity score for Wegener's granulomatosis (BVAS/WG) - Construct validity.
ανά: Maiden, N, κ.ά.
Έκδοση: (2000)

THE RELATIONSHIP BETWEEN BRAIN WHITE MATTER CHANGES AND FATIGUE IN GRANULOMATOSIS WITH POLYANGIITIS (GPA; WEGENER'S)
ανά: Basu, N, κ.ά.
Έκδοση: (2012)

Livedo retikularis pada penderita Granulomatosis Wegener SUATU LAPORAN KASUS.
ανά: Perpustakaan UGM, i-lib
Έκδοση: (1996)

Hypophyseal Wegener's granulomatosis presenting by visual field constriction without hypopituitarism.
ανά: Pereira, E, κ.ά.
Έκδοση: (2013)

Hypophyseal Wegener's granulomatosis presenting by visual field constriction without hypopituitarism
ανά: Pereira, E, κ.ά.
Έκδοση: (2013)

Strawberry gingivitis as the first presenting sign of Wegener's granulomatosis: report of a case
ανά: Siar, C.H., κ.ά.
Έκδοση: (2011)

Differences of the phenotype of CD4+ and CD8+ T-cell populations in Wegener's granulomatosis.
ανά: Lamprecht, P, κ.ά.
Έκδοση: (2003)

Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosis.
ανά: Lamprecht, P, κ.ά.
Έκδοση: (2003)

CMV-specific and non-specific CD8+T-cells display an altered phenotype in Wegener's granulomatosis.
ανά: Lamprecht, P, κ.ά.
Έκδοση: (2003)

Neural Correlates of Chronic Fatigue in Granulomatosis with Polyangiitis (GPA; Wegener's)-A Functional Magnetic Resonance Imaging (fMRI) Study
ανά: Basu, N, κ.ά.
Έκδοση: (2011)

Current evidence of factors influencing remission, relapse, renal failure and mortality in patients with systemic vasculitis. A systematic review for the EULAR systemic vasculitis task force
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2007)